Dr. Briggs Morrison is Chair of the Board at Actithera. He is Chief Executive Officer of Crossbow Therapeutics and an Entrepreneur Partner at MPM BioImpact. A trained medical oncologist, Briggs brings more than 30 years of leadership experience across the pharmaceutical and biotechnology industries, including executive roles at Syndax Pharmaceuticals, AstraZeneca, Pfizer, and Merck. Throughout his career, he has overseen the development of numerous oncology medicines from first-in-human studies through global regulatory approvals, bringing extensive expertise in advancing innovative therapies to patients. Dr. Morrison also serves on the boards of several public and private biotechnology companies and earned his B.S. in Biology from Georgetown University and his M.D. from the University of Connecticut.